Suchergebnisse - "*Ritonavir"

PubPharm (105)

51

Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy

enthalten in: HIV medicine | 2011

von Lambert, J. | Else, L. | Jackson, V. | +10

52

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients

enthalten in: HIV medicine | 2010

von Lambert-Niclot, S. | Machouf, N. | Peytavin, G. | +8

53

Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions

enthalten in: HIV medicine | 2010

von Rubio, R. | Serrano, O. | Carmena, J. | +103

54

No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy : a randomized trial

enthalten in: HIV medicine | 2010

von Calmy, A. | Bloch, M. | Wand, H. | +20

55

Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

enthalten in: HIV medicine | 2010

von Fabbiani, M. | Di Giambenedetto, S. | Ragazzoni, E. | +5

56

Lopinavir protein binding in HIV-1-infected pregnant women

enthalten in: HIV medicine | 2010

von Aweeka, F. | Stek, A. | Best, B. | +65

57

Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers

enthalten in: HIV medicine | 2010

von Luber, A. | Condoluci, D. | Slowinski, P. | +6

58

Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial

enthalten in: HIV medicine | 2010

von Ghosn, J. | Flandre, P. | Cohen-Codar, I. | +108

59

Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life : results from a multicentre cohort study

enthalten in: HIV medicine | 2010

von Giuntini, R. | Martinelli, C. | Ricci, E. | +11

ErratumIn: HIV Med. 2011 Feb;12(2):127

60

Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial

enthalten in: HIV medicine | 2009

von Hill, A. | Marcelin, A. | Calvez, V.